Editor's Choice: SENTIREC-endo study: Is the juice worth the squeeze?

Update: 2024-04-15

Description

Editor’s Choice Paper:
Identifying safe diagnostic algorithms for sentinel lymph node mapping in high-risk endometrial cancer: The SENTIREC-endo study

Editorial:
Sentinel lymph node biopsy in high-risk endometrial cancer: The dénouement

Hosted by:
Gregg Nelson, MD, Social Media Editor of Gynecologic Oncology

Featuring:
Sarah M. Bjørnholt, MD, Aarhus University Hospital, Denmark
Sean Dowdy, MD, Mayo Clinic, USA

Comments

In Channel

Cervical Cancer Care in Focus: Consensus on Quality, Equity, and Radiation Therapy

2025-09-2921:04

May 2023 Editor's Choice: Prioritizing and achieving diversity in clinical trial enrollment

2025-09-01--:--

Beyond Anesthesia: Self-Hypnosis in ERAS Programs

2025-08-2924:12

Carcinosarcoma Wars: A New Hope for TROP-2 Therapeutic Targeting

2025-07-1420:25

To divert or not to divert: that is the question

2025-07-0827:38

Understanding the Implications of the Platinum-Free Interval in Endometrial Cancer

2025-03-2716:12

Prophylactic chemotherapy to prevent post-molar gestational trophoblastic disease - a long journey and a remarkable study

2025-03-0318:12

Clinical trials: Panacea or pitfall

2025-01-2730:47

FOLR1 status: Landscape beyond high grade serous ovarian cancer

2024-12-3020:26

Benefits of hormonal therapy for low grade serous ovarian cancer

2024-12-3022:40

Implementation and impact of a financial navigation program in gynecologic oncology

2024-10-2332:25

LVSI in Stage 1 Endometrial Cancer

2024-09-2518:19

Primary Surgery versus Radiotherapy for Inguinal Lymph Nodes in Vulvar Cancer

2024-09-0231:59

Shifting trends and sicker patients - the future of gynecologic cancer

2024-07-1214:49

2023 FIGO staging for endometrial cancer: a reappraisal on the path to continuous improvement